Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?
Hsieh
Matthew M
MM
Molecular and Clinical Hematology Branch, National Institute of Diabetes, Digestive, and Kidney Diseases, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
Tisdale
John F
JF
Rodgers
Griffin P
GP
Young
Neal S
NS
Trimble
Edward L
EL
Little
Richard F
RF
D001741:Black or African American; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D005260:Female; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009503:Neutropenia / Q000139:chemically induced* / Q000175:diagnosis / Q000208:ethnology*; D009504:Neutrophils; D018579:Patient Selection
D000970:Antineoplastic Agents